Clinical Trial Update: Evaluate the Safety and Efficacy of Botulax® in Subjects With Benign Masseteric Hypertrophy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of Botulax® in subjects with benign masseteric hypertrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Masseteric Hypertrophy

Drugs mentioned

• Botulax (botulinum toxin type A)

Snippet

Sponsor: Hugel | Conditions: Benign Masseteric Hypertrophy | Phase 2 | Status: COMPLETED